HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

(3S)- 3- (((2S)- 2- (4,4- dimethyl- 3- (4- ((((2- methylphenyl)amino)carbonyl)amino)benzyl)- 2,5- dioxoimidazolidin- 1- yl)- 4- methylpentanoyl)amino)- 3- phenylpropanoic acid

integrin VLA-4 antagonist; structure in first source
Also Known As:
HMR 1031; HMR-1031; HMR1031
Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Rohatagi, S: 2 articles (08/2005 - 04/2004)
2. Hofmann, T: 2 articles (04/2004 - 04/2004)
3. Crofts, F: 2 articles (04/2004 - 04/2004)
4. Barbellion, S: 2 articles (04/2004 - 04/2004)
5. Brunel, P: 2 articles (04/2004 - 04/2004)
6. Pino, M: 2 articles (04/2004 - 04/2004)
7. DeLise, B: 2 articles (04/2004 - 04/2004)
8. Lerman, S: 2 articles (04/2004 - 04/2004)
9. Guittin, P: 2 articles (04/2004 - 04/2004)
10. Sterk, P J: 1 article (08/2005)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Inflammation
3. Congenital Abnormalities (Deformity)
4. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Integrin alpha4beta1 (VLA-4)
2. IVL 984
3. 3- (N- (3,4- dimethoxybenzyl)- 2- (2- (3- methoxy- 4- (3- o- tolylureido)phenyl)acetylamino)acetamido)propanoic acid

Related Therapies and Procedures

1. Nebulizers and Vaporizers (Inhaler)